Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells

Kidney International

Volumn 51, Issue 3, 1997, Pages 664-671

  Kagami, Shoji ^b   Kuhara, Takashi ^b   Okada, Kaname ^b   Kuroda, Yasuhiro ^b   Border, Wayne A ^b   Noble, Nancy A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANTIBODY; METALLOPROTEINASE; PLASMIN; PLASMINOGEN; SARALASIN; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ANIMAL CELL; ARTICLE; CELL CULTURE; EXTRACELLULAR MATRIX; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030928847     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.96     Document Type: Article

References (57)

1. ICHIKAWA I, HARRIS RC: Angiotensin actions in the kidney: Renewed insight into the old hormone. Kidney Int 40:583-596, 1991
2. WOLF G, NEILSON EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3:1531-1540, 1993
3. BURNS KD, HOMMA T, HARRIS RC: The intrarenal renin-angiotensin system. Semin Nephrol 13:13-30, 1993
4. SAJID M, GRAVES K, RAJARAMAN S: Mediators of progressive glomerular injury: Evidence for interplay of interleukin-1 beta (IL-1β) and angiotensin II (Ang II). (abstract) J Am Soc Nephrol 3:613, 1992
5. TERADA Y, TOMITA K, NONOGUCHI H, MARUMO F: PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int 43:1251-1259, 1993
6. WAGNER J, DRAB M, GEHLEN F, LANGHEINRICH M, COLK S, GANTEN D, RITZ E: PCR analysis of human renal biopsies - Renin gene regulation in glomerulonephritis. Kidney Int 46:1542-1545, 1994
7. KAKINUMA Y, KAWAMURA T, BILLS T, YOSHIOKA T, ICHIKAWA I, FOGO A: Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 42:46-55, 1992
8. KASHGARIAN M, STERZEL RB: The pathobiology of the mesangium. Kidney Int 40:524-529, 1992
9. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZI P, FLOEGE J, SCHWARTZ SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
10. WOLF G, HABERSTROH U, NEILSON EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107, 1992
11. HOMMA T: Angiotensin II induces hypertrophy and stimulates collagen production in cultured rat glomerular mesangial cell. (abstract) Clin Res 38:358, 1990
12. RAY PE, BRUGGEMAN LA, HORIKOSHI S, AGUILERA G, KLOTMAN PE: Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin synthesis by binding to AT1 receptors. Kidney Int 45:177-184, 1994
13. ROSENBERG ME, SMITH LJ, CORREA-ROTTER R, HOSTETTER TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45:403-410, 1994
14. BORDER WA, NOBLE NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
15. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
16. LEE L, MEYER TW, POLLACK AS, LOVETT DH: Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 96:953-964, 1995
17. BARICOS WH, CORTEZ SL, EL-DAHR SS, SCHNAPER HW: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47:1039-1047, 1995
18. TOMOOKA S, BORDER WA, MARSHALL BC, NOBLE NA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 42:1462-1469, 1992
19. OLSON JA JR, SHIVERICK KT, OGILVIE S, BUHI WC, RAIZADA MK: Angiotensin II induces secretion of plasminogen activator inhibitor 1 and a tissue metalloprotease inhibitor-related protein from rat brain astrocytes. Proc Natl Acad Sci USA 88:1928-1932, 1991
20. ZELEZNA B, RYDZEWSKI B, LU D, OLSON JA, SHIVERICK KT, TANG W, SUMNERS C, RAIZADA MK: Angiotensin-II induction of plasminogen activator inhibitor-1 gene expression in astroglial cells of normotensive and spontaneously hypertensive rat brain. Mol Endocrinol 6:2009-2017, 1992
21. VAUGHAN DE, LAZOS SA, TONG K: Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest 95:995-1001, 1995
22. FEENER EP, NORTHRUP JM, AIELLO LP, KING GL: Angiotensin II induces plasminogen activator inhibitor-I and-2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 95:1353-1362, 1995
23. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990
24. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta-1. Nature 346:371-374, 1990
25. GRANELLI-PIPERNO A, REICH E: A study of proteases and protease inhibitor complexes in biological fluids. J Exp Med 148:223-234, 1978
26. VASSALLI J-D, BELIN D: Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 214:187-191, 1987
27. MARSHALL BC, XU QP, RAO NV, BROWN BR, HOIDAL JR: Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1β and tumor necrosis factor-α. J Biol Chem 267:11462-11469, 1992
28. BRUZDZINSKI CJ, RIORDAN-JOHNSON M, NORDBY EC, SUTER SM, GELEHRTER TD: Isolation and characterization of the rat plasminogen activator inhibitor-1 gene. J Biol Chem 265:2078-2084, 1990
29. DERYNCK R, JARRETT A, CHEN EY, GOEDDEL DV: The murine transforming growth factor-β precursor. J Biol Chem 261:4377-4379, 1986
30. FORT P, MARTY L, PIECHACZYK M, SABROUTY SE, DANI C, JEANTEUR PH, BLANCHARD JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucl Acids Res 13:1431-1442, 1985
31. SEIKALY MG, ARANT BS JR, SENEY FD JR: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86:1352-1357, 1990
32. RAGNO P, CASSANO S, DEGEN J, KESSLER C, BLASI F, ROSSI G: The receptor for the plasminogen activator of urokinase type is upregulated in transformed rat thyroid cells. FEBS Lett 306:193-198, 1992
33. KANALAS JJ: Analysis of the plasminogen system on rat glomerular epithelial cells. Exp Cell Res 218:561-566, 1995
34. ROSENBERG ME, CORREA-ROTTER R, INAGAMI T, KREN SM, HOSTETTER TH: Glomerular renin synthesis and storage in the remnant kidney in the rat. Kidney Int 40:677-683, 1991
35. ANDERSON S, JUNG FF, INGELFINGER JR: Renal renin-angiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265:F477-F486, 1993
36. LEWIS E, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
37. ARAI M, WADA A, ISAKA Y, AKAGI Y, SUGIURA T, MIYAZAKI M, MORIYAMA T, KANEDA Y, NARUSE K, NARUSE M, ORITA Y, ANDO A, KAMADA T, UEDA N, IMAI E: In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cels and glomerular sclerosis. Biochem Biophys Res Commun 206:525-532, 1995
38. WOLF G, ZIYADEH FN, ZAHNER G, STAHL RAF: Angiotensin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: Attenuation after stable transfection with c-mas oncogene. Kidney Int 48:1818-1827, 1995
39. NISHIMURA M, OKAMURA M, KONISHI Y, INOUE K, YOUNG CK, YOSHIOKA T, NEGORO N, INOUE T, KANAYAMA Y: Effect of treatment with ACE inhibitor (ACEI) on TGF-beta gene expressions in renal biopsy from patients with IgA nephropathy. (abstract) J Am Soc Nephrol 6:397, 1995
40. JUNAID A, ROSENBERG ME, HOSTETTER TH: Interaction of angiotensin II (All) and transforming growth factor beta (TGF-β) in the remnant kidney. (abstract) J Am Soc Nephrol 4:772, 1993
41. SHANKLAND SJ, LY H, THAI K, SCHOLEY JW: Increased glomerular capillary pressure alters glomerular cytokine expression. Circ Res 75:844-853, 1994
42. PIMENTEL JL JR, SUNDELL CL, WANG S, KOPP JB, MONTERO A, MARTINEZ-MALDONADO M: Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int 48:1233-1246, 1995
43. KIM S, OHTA K, HAMAGUCHI A, OMURA T, YUKIMURA T, MIURA K, INADA Y, WADA T, ISHIMURA Y, CHATANI F, IWAO H: Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 24:195-204, 1994
44. PICHLER RH, YOUNG BA, HUGO C, SHANKLAND SJ, ALPERS CE, COUSER WG, JOHNSON RJ, FRANCESCHINI N, ANDOH TF, BURDMANN EA, BENNETT WM: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196, 1995
45. OHTA K, KIM S, HAMAGUCHI A, YUKIMURA T, MIURA K, TAKAORI K, IWAO H: Role of angiotensin II in extracellular matrix and transforming growth factor-β1 expression in hypertensive rats. Eur J Pharmacol 269:115-119, 1994
46. KIM S, OHTA K, HAMAGUCHI A, OMURA T, YUKIMURA T, MIURA K, INADA Y, WADA T, ISHIMURA Y, CHATANI F, IWAO H: Contribution of renal angiotensin II type 1 receptor to gene expressions in hypertension-induced renal injury. Kidney Int 46:1346-1358, 1994
47. RUIZ-ORTEGA M, GONZALEZ S, SERON D, CONDOM E, BUSTOS C, LARGO R, GONZALEZ E, ORTIZ A, EGIDO J: ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 48:1778-1891, 1995
48. LAIHO M, SAKSELA O, ANDREASEN PA, KESKI-OJI J: Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human fibroblasts by transforming growth factor-beta. J Clin Biol 103:2403-2410, 1986
49. LUND LR, RICCIO A, ANDREASEN AP, NIELSEN LS, KRISTENSEN P, LAIHO M, BLASI F, DANO K: Transforming growth factor-β is a strong and fast acting positive regulator of the level of type I plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J 6:1281-1286, 1987
50. ANDREASEN PA, GEORG B, LUND LR, RICCIO A, STACEY SN: Plasminogen activator inhibitors: Hormonally regulated serpins. Mol Cell Endocrinol 68:1-19, 1990
51. CARMELIET P, SCHOONJANS L, KIECKENS L, REAM B, DEGEN J, BRONSON R, Vos RD, OORD JJ, COLLEN D, MULLIGAN RC: Physiological consequences of loss of plasinogen activator gene function in mice. Nature (Lond) 368:419-423, 1994
52. EITZMAN DT, MCCOY RD, ZHENG X, FAY WP, SHEN T, GINSBURG D, SIMON RH: Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack of overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97:232-237, 1996
53. FENG L, TANG WW, LOSKUTOFF DJ, WILSON CB: Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. J Am Soc Nephrol 3:1753-1764, 1993
54. LOSKUTOFF DJ, SAWDEY M, KEETON M, SCHNEIDERMAN J: Regulation of PAI-1 gene expression in vivo. Thromb Haemostasis 70:135-137, 1993
55. RONDEAU E, MOUGENOT B, LACAVE R, PERALDI MN, KRUITHOF EKO, SRAER JD: Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies. Clin Nephrol 33:55-60, 1990
56. SHIHAB FS, YAMAMOTO T, NAST CC, COHEN AH, NOBLE NA, GOLD LI, BORDER WA: Transforming growth factor-β and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol 6:286-294, 1995
57. YAMAMOTO T, NOBLE NA, COHEN AH, NAST CC, HISHIDA A, GOLD LI, BORDER WA: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996